Redhill Biopharma Ltd (NASDAQ:RDHL)

17.55
Delayed Data
As of Jul 06
 +0.03 / +0.17%
Today’s Change
6.89
Today|||52-Week Range
22.22
+31.66%
Year-to-Date

Stock Price Forecast

The 4 analysts offering 12-month price forecasts for Redhill Biopharma Ltd have a median target of 31.00, with a high estimate of 33.00 and a low estimate of 29.00. The median estimate represents a +76.64% increase from the last price of 17.55.

Analyst Recommendations

The current consensus among 4 polled investment analysts is to Buy stock in Redhill Biopharma Ltd. This rating has held steady since June, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.36
Sales
$25.3K
Reporting Date
Jul 22

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -610.00%
 
 
 
 
 
 
Growthannually -12.88%
 
 
 
 
 

Sales

Growthquarterly 2,425.00%
 
 
 
 
 
 
Growthannually -98.56%
 
 
 
 
 
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account